Dulaglutide news

All news on Dulaglutide (also known as Trulicity): plants, production capacities, investments and involved companies.

28 August 2026

Eli Lilly’s Mounjaro approved by FDA to reduce cardiovascular risk in adults with type 2 diabetes

First GIP+GLP‑1 agonist authorised to lower major adverse cardiovascular events in high‑risk adults with type 2 diabetes; SURPASS‑CVOT enrolled >13,000 with ~4‑year median follow‑up.

Who will be producing Dulaglutide in the future?

Find out with chemXplore Alpha

Learn more